|
1
|
Young A and Okuyemi OT: Malignant salivary
gland tumors. In: StatPearls. StatPearls Publishing, Treasure
Island, FL, 2025.
|
|
2
|
Ouyang DQ, Liang LZ, Zheng GS, Ke ZF, Weng
DS, Yang WF, Su YX and Liao GQ: Risk factors and prognosis for
salivary gland adenoid cystic carcinoma in southern china: A
25-year retrospective study. Medicine (Baltimore).
96(e5964)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dillon PM, Chakraborty S, Moskaluk CA,
Joshi PJ and Thomas CY: Adenoid cystic carcinoma: A review of
recent advances, molecular targets, and clinical trials. Head Neck.
38:620–627. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu Y, Han T, Guo D, Chen D and Li Y:
Exploring potential treatment opportunities in a head and neck
tumor patient with AdCC: A novel germline ERCC2 mutation case
report. Medicine (Baltimore). 104(e41233)2025.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zupancic M, Näsman A, Friesland S and
Dalianis T: Adenoid cystic carcinoma, clinical presentation,
current treatment and approaches towards novel therapies.
Anticancer Res. 44:1325–1334. 2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ferrarotto R, Mitani Y, Diao L, Guijarro
I, Wang J, Zweidler-McKay P, Bell D, William WN Jr, Glisson BS,
Wick MJ, et al: Activating NOTCH1 mutations define a distinct
subgroup of patients with adenoid cystic carcinoma who have poor
prognosis, propensity to bone and liver metastasis, and potential
responsiveness to notch1 inhibitors. J Clin Oncol. 35:352–360.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wagner VP, Bingle CD and Bingle L:
Myb-nfib fusion transcript in adenoid cystic carcinoma: Current
state of knowledge and future directions. Crit Rev Oncol Hematol.
176(103745)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nordfors C, Grün N, Tertipis N,
Ährlund-Richter A, Haeggblom L, Sivars L, Du J, Nyberg T, Marklund
L, Munck-Wikland E, et al: CD8+ and CD4+ tumour infiltrating
lymphocytes in relation to human papillomavirus status and clinical
outcome in tonsillar and base of tongue squamous cell carcinoma.
Eur J Cancer. 49:2522–2530. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Näsman A, Romanitan M, Nordfors C, Grün N,
Johansson H, Hammarstedt L, Marklund L, Marklund L, Munck-Wikland
E, Dalianis T and Ramqvist T: Tumor infiltrating CD8+ and Foxp3+
lymphocytes correlate to clinical outcome and human papillomavirus
(HPV) status in tonsillar cancer. PLoS One.
7(e38711)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Näsman A, Andersson E, Nordfors C, Grün N,
Johansson H, Munck-Wikland E, Massucci G, Dalianis T and Ramqvist
T: MHC class I expression in HPV positive and negative tonsillar
squamous cell carcinoma in correlation to clinical outcome. Int J
Cancer. 132:72–81. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Koike K, Dehari H, Shimizu S, Nishiyama K,
Sonoda T, Ogi K, Kobayashi J, Sasaki T, Sasaya T, Tsuchihashi K, et
al: Prognostic value of HLA class I expression in patients with
oral squamous cell carcinoma. Cancer Sci. 111:1491–1499.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Caballero-Borrego M, Grau JJ, Basté N,
Castillo PC, Teixido C, Valduvieco I and Vilaseca I: Cancer stem
cell biomarkers in locally advanced head and neck squamous cell
carcinoma. Braz J Otorhinolaryngol. 91(101689)2025.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zupancic M, Holzhauser S, Cheng L,
Ramqvist T, Du J, Friesland S, Näsman A and Dalianis T: Analysis of
human papillomavirus (HPV) and polyomaviruses (HPYVS) in adenoid
cystic carcinoma (ADCC) of the head and neck region reveals three
HPV-positive cases with adenoid cystic-like features. Viruses.
14(1040)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zupancic M, Nasman A, Berglund A, Dalianis
T and Friesland S: Adenoid cystic carcinoma (ADCC): A clinical
survey of a large patient cohort. Cancers (Basel).
15(1499)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
de Flon CH, Haeggblom L, Holzhauser S,
Kostopoulou ON, Zupancic M, Dalianis T, Munck-Wikland E, Marklund L
and Näsman A: High levels of FGF11 correlate with poor survival in
patients with human papillomavirus (HPV)-positive oropharyngeal
squamous cell carcinoma. Cancers (Basel). 15(1954)2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rötzschke O, Falk K, Deres K, Schild H,
Norda M, Metzger J, Jung G and Rammensee HG: Isolation and analysis
of naturally processed viral peptides as recognized by cytotoxic T
cells. Nature. 348:252–254. 1990.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Schulz M, Aichele P, Schneider R, Hansen
TH, Zinkernagel RM and Hengartner H: Major histocompatibility
complex binding and T cell recognition of a viral nonapeptide
containing a minimal tetrapeptide. Eur J Immunol. 21:1181–1185.
1991.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dersh D, Hollý J and Yewdell JW: A few
good peptides: MHC class I-based cancer immunosurveillance and
immunoevasion. Nat Rev Immunol. 21:116–128. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang K, Halima A and Chan TA: Antigen
presentation in cancer-mechanisms and clinical implications for
immunotherapy. Nat Rev Clin Oncol. 20:604–623. 2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kong S, Zhang J, Wang L, Li W, Guo H, Weng
Q, He Q, Lou H, Ding L and Yang B: Mechanisms of low MHC I
expression and strategies for targeting MHC I with small molecules
in cancer immunotherapy. Cancer Lett. 611(217432)2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Darabi A, Thuring C and Paulsson KM: HLA-I
antigen presentation and tapasin influence immune responses against
malignant brain tumors-considerations for successful immunotherapy.
Anticancer Agents Med Chem. 14:1094–1100. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Emtiazi N, Zolfi E, Mehr FK and Moradi Y:
The role of the major histocompatibility complex (MHC) class I in
prostate cancer therapy: A review. Crit Rev Oncol Hematol.
215(104897)2025.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tang YF, An PG, Gu BX, Yi S, Hu X, Wu WJ
and Zhang J: Transcriptomic insights into adenoid cystic carcinoma
via RNA sequencing. Front Genet. 14(1144945)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li A, Gonda BL, Codd EM, von Paternos A,
Mitchell DR, Herrmann MD, Kalyan P, Flynn SE, Dzu TQ, Gao C, et al:
Reversible downregulation of HLA class I in adenoid cystic
carcinoma. J Immunother Cancer. 13(e011380)2025.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mosconi C, de Arruda JAA, de Farias ACR,
Oliveira GAQ, de Paula HM, Fonseca FP, Mesquita RA, Silva TA,
Mendonça EF and Batista AC: Immune microenvironment and evasion
mechanisms in adenoid cystic carcinomas of salivary glands. Oral
Oncol. 88:95–101. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Campo MS, Graham SV, Cortese MS, Ashrafi
GH, Araibi EH, Dornan ES, Miners K, Nunes C and Man S: HPV-16 E5
down-regulates expression of surface HLA class I and reduces
recognition by CD8 T cells. Virology. 407:137–142. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Georgopoulos NT, Proffitt JL and Blair GE:
Transcriptional regulation of the major histocompatibility complex
(MHC) class I heavy chain, TAP1 and LMP2 genes by the human
papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene.
19:4930–4935. 2000.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kesar N, Winkelmann R, Oppermann J,
Ghanaati S, Martin D, Neumayer T, Balster S, Rödel C, Rödel F, von
der Grün J and Balermpas P: Prognostic impact of CD8-positive
tumour-infiltrating lymphocytes and PD-L1 expression in salivary
gland cancer. Oral Oncol. 111(104931)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Doescher J, Meyer M, Arolt C, Quaas A,
Klußmann JP, Wolber P, Bankfalvi A, Schildhaus HU, Bastian T, Lang
S, et al: Patterns of tumor infiltrating lymphocytes in adenoid
cystic carcinoma of the head and neck. Cancers (Basel).
14(1383)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
de Morais EF, da Silva LP, Moreira DGL,
Mafra RP, Rolim LSA, de Moura Santos E, de Souza LB and de Almeida
Freitas R: Prognostic factors and survival in adenoid cystic
carcinoma of the head and neck: A retrospective clinical and
histopathological analysis of patients seen at a cancer center.
Head Neck Pathol. 15:416–424. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Spiro RH and Huvos AG: Stage means more
than grade in adenoid cystic carcinoma. Am J Surg. 164:623–628.
1992.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ko JJ, Siever JE, Hao D, Simpson R and Lau
HY: Adenoid cystic carcinoma of head and neck: Clinical predictors
of outcome from a canadian centre. Curr Oncol. 23:26–33.
2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ju J, Li Y, Chai J, Ma C, Ni Q, Shen Z,
Wei J and Sun M: The role of perineural invasion on head and neck
adenoid cystic carcinoma prognosis: A systematic review and
meta-analysis. Oral Surg Oral Med Oral. 122:691–701.
2016.PubMed/NCBI View Article : Google Scholar
|
